Company: BIVIW
Filing Date: 2025-08-08
Form Type: 424B5
Source: 0001520138-25-000247
Chunk: 151

Company: BIOVIE INC.
Filing Date: 2025-08-08
Form: 424B5
Chunk 151
---
<div align='center'>86

INDEX TO FINANCIAL STATEMENTS

BIOVIE INC.</div>

Audited Financial Statements

| Report of Independent Registered Public Accounting Firm - EisnerAmper LLP (PCAOB Number 274) 
 Balance Sheets as of June 30, 2024 and 2023                                                  
 Statements of Operations and Comprehensive Loss for the Years Ended June 30, 2024 and 2023   | F-2 
 F-4 
 F-5 |
|:---------------------------------------------------------------------------------------------|:----|
| Statements of Changes in Stockholders’ Equity for the Years Ended June 30, 2024 and 2023     | F-6 |
| Statements of Cash Flows for the Years Ended June 30, 2024 and 2023                          | F-7 |
| Notes to Audited Financial Statements                                                        | F-8 |

Unaudited Financial Statements

| Condensed Balance Sheets as of March 31, 2025 and June 30, 2024                                                                                          
 Condensed Statements of Operations and Comprehensive Loss for the Three and Nine Months Ended March 31, 2025 and 2024                                    | F-26 
 F-27 |
|:---------------------------------------------------------------------------------------------------------------------------------------------------------|:-----|
| Condensed Statements of Changes in Stockholders’ Equity for the Periods From July 1, 2024 Through March 31, 2025 and July 1, 2023 Through March 31, 2024 | F-28 |
| Condensed Statements of Cash Flows for the Nine Months Ended March 31, 2025 and 2024                                                                     | F-29 |
| Notes to Unaudited Condensed Financial Statements                                                                                                        | F-30 |

<div align='center'>F-1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>

To the Board of Directors and Stockholders of

BioVie, Inc.

Opinion on the Financial Statements

We have audited the accompanying balance sheets of
BioVie, Inc. (the “Company”) as of June 30, 2024 and 2023, and the related statements of operations and comprehensive loss,
changes in stockholders’ equity, and cash flows for each of the years then ended, and the related notes (collectively referred to
as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial
position of the Company as of June 30, 2024